help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krishnamani, M. R.
Right arrow Articles by Copeland, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krishnamani, M. R.
Right arrow Articles by Copeland, K. C.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 596-598, Copyright © 1993 by Endocrine Society


ARTICLES

Detection of a novel arginine vasopressin defect by dideoxy fingerprinting

MR Krishnamani, JA Phillips 3d and KC Copeland
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2578.

Autosomal dominant neurohypophyseal diabetes insipidus is a familial form of diabetes insipidus. This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP. To determine the molecular basis of autosomal dominant neurohypophyseal diabetes insipidus, the AVP genes of members of a large kindred were analyzed. A new method, called dideoxy fingerprinting, was used to detect an AVP mutation that was characterized by DNA sequencing. The novel defect found changes the last codon of the AVP signal peptide from alanine to threonine, which should perturb cleavage of mature AVP from its precursor protein and inhibit its secretion or action.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. P. Mahoney, E. Weinberger, C. Bryant, M. Ito, J. L. Jameson, and M. Ito
Effects of Aging on Vasopressin Production in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus Due to the {Delta}E47 Neurophysin Mutation
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 870 - 876.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Calvo, J. R. Bilbao, A. Rodríguez, M. D. Rodríguez-Arnao, and L. Castaño
Molecular Analysis in Familial Neurohypophyseal Diabetes Insipidus: Early Diagnosis of an Asymptomatic Carrier
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3351 - 3354.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
M. D. Willcutts, E. Felner, and P. C. White
Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin
Hum. Mol. Genet., July 1, 1999; 8(7): 1303 - 1307.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ito, R. N. Yu, J. L. Jameson, and M. Ito
Mutant Vasopressin Precursors That Cause Autosomal Dominant Neurohypophyseal Diabetes Insipidus Retain Dimerization and Impair the Secretion of Wild-type Proteins
J. Biol. Chem., March 26, 1999; 274(13): 9029 - 9037.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. D. Grant, A. Ahmadi, C. M. Hosley, and J. A. Majzoub
Two Novel Mutations of the Vasopressin Gene Associated with Familial Diabetes Insipidus and Identification of an Asymptomatic Carrier Infant
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3958 - 3964.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Calvo, J. R. Bilbao, I. Urrutia, J. Eizaguirre, S. Gaztambide, and L. Castaño
Identification of a Novel Nonsense Mutation and a Missense Substitution in the Vasopressin-Neurophysin II Gene in Two Spanish Kindreds with Familial Neurohypophyseal Diabetes Insipidus
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 995 - 997.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. C. Gagliardi, S. Bernasconi, and D. R. Repaske
Autosomal Dominant Neurohypophyseal Diabetes Insipidus Associated with a Missense Mutation Encoding Gly23->Val in Neurophysin II
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3643 - 3646.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. R. Repaske, R. Medlej, E. K. Gultekin, M. R. S. Krishnamani, G. Halaby, J. W. Findling, and J. A. Phillips III
Heterogeneity in Clinical Manifestation of Autosomal Dominant Neurohypophyseal Diabetes Insipidus Caused by a Mutation Encoding Ala-1->Val in the Signal Peptide of the Arginine Vasopressin/Neurophysin II/Copeptin Precursor
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 51 - 56.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society